These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6047292)

  • 1. [Configurative and cosmetic effects of steroid mixtures].
    Stĕrba R; Valová B
    Cas Lek Cesk; 1967 Mar; 106(9):236-8. PubMed ID: 6047292
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of woman with sex steroids].
    Staemmler HJ
    Ther Ggw; 1968 Sep; 107(9):1104 passim. PubMed ID: 5717231
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone therapy of tumors in gynecology].
    Kaiser R
    Z Allgemeinmed; 1969 Mar; 45(7):301-8. PubMed ID: 5778600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interactions of the effects of various steroid structures. II. Anti-lipid and anti-atheromatous effects].
    Savini EC
    Therapie; 1966; 21(4):959-66. PubMed ID: 5925090
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between mammographic density and duration of hormone therapy: effects of estrogen and estrogen-progestin.
    Chen FP; Cheung YC; Teng LF; Soong YK
    Hum Reprod; 2005 Jun; 20(6):1741-5. PubMed ID: 15845600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effectiveness of drugs as determined by DESI reports. II.
    Calesnick B
    Semin Drug Treat; 1973; 3(3):315-9. PubMed ID: 4130521
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the hormonal treatment of metastatic mammary carcinoma].
    Pickert H
    Ther Ggw; 1965 Oct; 104(10):1327-37. PubMed ID: 5879858
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postmenopausal osteoporosis: therapeutic approaches].
    Affinito P; Palomba S; Sorrentino C; Pellicano M; Morgera R; Nappi C
    Minerva Ginecol; 1997 Mar; 49(3):109-20. PubMed ID: 9173338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestins in the menopause in healthy women and breast cancer patients.
    Pasqualini JR
    Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibolone: new preparation. Menopausal symptoms: oestrogen-progestogen combinations are still the reference treatment.
    Prescrire Int; 2002 Jun; 11(59):79-82. PubMed ID: 12068842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the effects of androgen therapy on sexual well-being: a complex challenge.
    Davis SR
    Menopause; 2005; 12(4):359-60. PubMed ID: 16037748
    [No Abstract]   [Full Text] [Related]  

  • 12. Endocrine treatment of breast cancer.
    Ravdin PM
    Curr Ther Endocrinol Metab; 1994; 5():556-62. PubMed ID: 7704791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estrogens, progestins and the bone].
    Ribot C
    Rev Prat; 1993 Dec; 43(20):2619-23. PubMed ID: 8146561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogens and progestins in replacement therapy in menopause].
    Lansac J; Lecomte P; Gillard P
    Contracept Fertil Sex; 1995 Jan; 23(1):12-7. PubMed ID: 7881486
    [No Abstract]   [Full Text] [Related]  

  • 16. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks.
    Moskowitz D
    Altern Med Rev; 2006 Sep; 11(3):208-23. PubMed ID: 17217322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogen therapies: differences in clinical effects?
    Wiegratz I; Kuhl H
    Trends Endocrinol Metab; 2004 Aug; 15(6):277-85. PubMed ID: 15358281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-contraceptive use of progestins.
    McDonough PG; Cardosa D
    J Med Assoc Ga; 1970 May; 59(5):181-7. PubMed ID: 5431709
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of metastatic breast cancer.
    Peters W
    Adv Intern Med; 1995; 40():341-64. PubMed ID: 7747652
    [No Abstract]   [Full Text] [Related]  

  • 20. NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit.
    South Med J; 2002 Aug; 95(8):795-7. PubMed ID: 12190211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.